From: Targeting the orphan nuclear receptor NR2F6 in T cells primes tumors for immune checkpoint therapy
Gene | Target Sequence | Order # |
---|---|---|
Cd44.01 | TATGGTAACCGGTCCATCGA | CR-041132-01-0020 |
Cd44.02 | GTCCATCGAAGGAATTGGGT | CR-041132-02-0020 |
Cd44.03 | GTTGGCTGCACAGATAGCGT | CR-041132-03-0020 |
Cd44.04 | TCTGCATCGCGGTCAATAGT | CR-041132-04-0020 |
Cd44.05 | CATGGAATACACCTGCGTAG | CR-041132-05-0020 |
Cd69.01 | ATGTATCCTCGTCATCTGGA | CM-057343-01-0020 |
Cd69.02 | CATTCTTGCAGGTAGCAACA | CM-057343-02-0020 |
Cd69.03 | CATCTTCAGAACAAGAGCGT | CM-057343-03-0020 |
Cd69.04 | GCAATTGTACTTGCCCACTG | CM-057343-04-0020 |
Cd69.05 | CTCCACCACAACCAAGAGTT | CM-057343-05-0020 |
Nr2f6.01 | AATCGTCCTCGGTCGCGCGT | CM-045088-01-0020 |
Nr2f6.02 | GCTGTTCAGCACGGTCGAGT | CM-045088-02-0020 |
Nr2f6.03 | TCCCGGATGAGGGTCTCGAT | CM-045088-03-0020 |
Nr2f6.04 | CTCAAGAAGTGCTTCCGGGT | CM-045088-04-0020 |
Nr2f6.05 | AGGTGTAGCTGAGATTGCGG | CM-045088-05-0020 |